Navigation Links
NW Bio Responds To Shareholder Inquiries Following Immune Therapy Sector's Recent Market Decline
Date:12/16/2013

NW Bio's Phase III trial is also potentially powered for the secondary endpoint of overall survival (OS), and it has an interim analysis devoted solely to reviewing the size of the trial, which can enable increasing the size of the trial if desired.  In addition to all these measures, the trial has built-in analyses of specified subsets of the patients in the trial.

In contrast, the Competitor's trial was a 124-patient Phase II trial.  It was approved by only one regulator (FDA) and conducted only in the US.  According to the Competitor's description of its trial, the trial was designed with a target of 9 months' difference in overall survival between the treated arm and the control arm in the trial.  It is unclear to what extent a cushion was built into the statistical powering in this trial design.  

Company Positioning Differences.  NW Bio has undertaken years of work and devoted extensive resources to building many chances for success.  The Company now has two potential major value-driver programs under way in parallel:  its lead Phase III trial with DCVax-L for GBM brain cancer, and its large (60 patient) Phase I/II trial with DCVax-Direct for all types of inoperable solid tumors with a particularly significant efficacy endpoint (regression of existing inoperable tumors). 

Each of these parallel programs are expected to have ongoing catalysts throughout 2014.  Each of these product lines has the possibility for broad market potential:  DCVax-L potentially for all or most types of operable solid tumors (i.e., tumors in any tissue of the body, which can be surgically removed) and DCVax-Direct potentially for all or most inoperable solid tumors (i.e., tumors in any tissues, which cannot be surgically removed).  NW Bio has also painstakingly built its operations on two continents, in both the US and Europe – including
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Icahn Responds To Forest Labs Board
2. iMD Companies responds to shareholder questions
3. Concord Medical Responds to Unusual Market Activity in its Stock
4. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
5. Medbox Responds to Unprecedented Rise in Stock Price
6. TorkLaw Responds to FDA Warning Letter to St. Jude Medical Regarding Defective Heart Device; Now Representing Patients in 15 States
7. Star Scientific Responds to Plaintiffs Purported Class Action Lawsuit
8. Takeda Responds to Verdict in Diabetes Drug Case
9. National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill
10. Royalty Pharma Responds To Elans Tysabri Valuation
11. Inovio Pharmaceuticals Responds to Market Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... quantum dot market report analyzes the ecosystem of the quantum ... includes medical devices, display, and others. The others segment consists ... QD laser, and transistor. The application segment covers the market ... report also provides the geographic view for major regions like ... , Asia-Pacific (APAC), and Rest ...
(Date:9/2/2015)... Colo. , Sept. 2, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in Boston.  The public is welcome ... on the Array BioPharma website.Event: Wells Fargo Securities ... Thursday, September 10, 2015Time:  , 10:20 a.m. Eastern ...
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye, today announced that its Board of ... Company,s Board. Mr. Wall was formerly the ... -based investment firm, for more than nine years. Mr. Wall ... chair of the Corporate Governance Committee and member of the ...
Breaking Medicine Technology:Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... 17, 2012  Tengion, Inc. (NASDAQ: TNGN ), ... recently completed a successful Pre-IND meeting with the U.S. ... program, the Neo-Kidney Augment™. The FDA and the Company ... study program required to support an Investigational New Drug ...
... Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" ... Distribution Specialists, LLC ("HDS") are pleased to announce that ... and Hemostasis Summit of North America (the "THSNA") to ... Chicago.  "Participation as an official exhibitor ...
Cached Medicine Technology:Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 2Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 3Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 4Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 5Sunpeaks Ventures to Exhibit Clotamin at the first-ever Thrombosis and Hemostasis Summit of North America 2
(Date:9/3/2015)... ... ... types of people who have a hard time gaining weight , it seems that ... those that have a fast metabolism. In order to help those people who have a ... slowing down metabolism. , The first thing to do is to space out meals. When ...
(Date:9/3/2015)... ... , ... James Earl Jones will be hosting an upcoming VOICES IN AMERICA ... will introduce a segment that discusses why it is important for the workplace to ... fostered in any working environment. , Employers are out billions of dollars year after ...
(Date:9/3/2015)... ... September 03, 2015 , ... The partnership will ... and technical support services to promote LodonalTM in Nigeria. The distribution will become ... efficacy and safety of the product. , Managing Director, Fidson Healthcare Plc, Dr ...
(Date:9/2/2015)... ... , ... Leah Binder, MA, MGA, president and CEO of ... will offer the keynote address at the upcoming meeting of the ACO and ... Florida, at the Innisbrook Resort and Golf Club. For an agenda and registration, ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... ... nominations to determine who among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, ... nation’s health care. This year, that process led the magazine to tap the ...
Breaking Medicine News(10 mins):Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... need to make tough choice on whether it,s worthwhile, ... Implanted defibrillators don,t seem to provide any particular ... study finds. , A defibrillator can provide a lifesaving ... be fatal. But it generally does nothing for heart ...
... common elective medical proceduresEAGAN, Minn., March 16 Consumers ... quality information through Care Comparison(R), a new online tool ... Minnesota. Care Comparison allows nearly two million Blue Cross ... well as quality, safety and accessibility information for dozens ...
... - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... of investigators (lead by Professor Mirjana Stojiljkovic) from ... Stankovic", University of Belgrade, Serbia, (IBISS group) introduced ... sclerosis (MS), a severe, currently incurable, human disease. ...
... Dr. Eleanor Rogen of the University of Nebraska ... located in Omaha, Nebraska, have identified the triggering ... begin. Preventium http://www.preventium.org is a recently ... risk for breast and prostate cancer. Ercole Cavalieri, ...
... SB 1022/HB 675 Bill Would Provide Access to ... Failure Patients Who QualifyTALLAHASSEE, Fla., March 16 ... Florida) praised Senator Thad Altman and Representative Ritch ... provide access to secondary health insurance for Florida,s ...
... International, Inc.,(Nasdaq: DATA ), a technology and ... trials industry, today announced its operating,results for the fourth ... Revenue for the fourth quarter of 2008 ... period of 2007. Gross profit margin,improved to 80% for ...
Cached Medicine News:Health News:Defibrillator May Not Help Many With Heart Failure 2Health News:Defibrillator May Not Help Many With Heart Failure 3Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 2Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 3Health News:Hard to Treat Diseases (HTDS) Releases experimental results in the treatment of (MS) Multiple Sclerosis 2Health News:The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida' 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 2Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 3Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 4Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 5Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 6Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 7Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 8Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 9Health News:DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 10
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Plus Sterile Isopropyl Alcohol ... primarily used as a ... administering injections. They are ... AAMI/ANSI/ISO 11137 standards to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
Medicine Products: